In biopharmaceutical manufacturing, compliance depends on more than documenting problems after they occur. Organizations must identify the source of a deviation, correct the immediate issue, prevent it from happening again, and demonstrate that every action was completed effectively.
Corrective and Preventive Action (CAPA) programs are designed to accomplish these goals, but they can fall short when they are disconnected from asset management.
Laboratory instruments, manufacturing equipment, utilities, environmental monitoring systems, and supporting infrastructure all influence product quality. When these assets are not properly maintained, calibrated, qualified, or tracked, they can become recurring sources of deviations. Integrating CAPA and asset management helps biopharma organizations close this compliance gap while improving reliability, traceability, and inspection readiness.
Why CAPA and Asset Management Must Work Together
A CAPA investigation may identify equipment failure, missed preventive maintenance, calibration drift, or an outdated procedure as a contributing factor. However, documenting the root cause is only the beginning. The organization must translate the investigation into controlled asset-related actions.
Those actions might include repairing or replacing equipment, revising a preventive maintenance schedule, updating calibration frequencies, retraining technicians, modifying spare-parts requirements, or requalifying an affected system. If CAPA activities and asset records are managed separately, important tasks may be delayed, duplicated, or completed without sufficient evidence.
An integrated approach creates a traceable connection between the quality event and the affected asset. Investigators can review work orders, breakdowns, alarm events, calibration results, qualification status, and previous deviations to determine whether an issue is isolated or part of a trend.
Common Compliance Gaps in Biopharma Facilities
Common gaps include incomplete equipment histories and poor coordination among quality, engineering, metrology, laboratory operations, and maintenance teams. Fragmented records can conceal recurring failures, while repairs may be completed without full awareness of related quality commitments.
Other potential gaps include:
CAPA tasks that are not linked to controlled work orders
Preventive maintenance frequencies that are not updated after failures
Calibration out-of-tolerance events that are not adequately trended
Repairs completed without assessing requalification requirements
Inconsistent equipment identification across systems
CAPAs closed before effectiveness can be meaningfully verified
These weaknesses can lead to repeat deviations, longer investigations, production interruptions, and increased regulatory risk.
How a CMMS Supports CAPA Execution
A computerized maintenance management system (CMMS) can provide the operational structure needed to carry out asset-related CAPA commitments. When appropriately configured and governed, a CMMS centralizes asset data, maintenance procedures, schedules, work orders, parts usage, service history, and supporting documentation.
For example, if a CAPA requires more frequent preventive maintenance on a critical incubator, the revised schedule can be entered into the CMMS and automatically generate future work orders. If the action requires replacement of a component, the work order can document the technician, date, parts used, approvals, and completion evidence.
Dashboards and notifications can highlight overdue tasks, while reports demonstrate completion and provide data for effectiveness checks. A CMMS does not replace the quality management system or CAPA procedure; it supports controlled execution and reliable evidence.
Improving Root Cause Analysis With Asset Data
Effective CAPA depends on accurate, complete, and accessible data. Asset history can reveal patterns that may not be apparent from a single deviation. Repeated bearing failures, increasing calibration adjustments, recurring temperature alarms, or frequent emergency work orders may indicate a systemic problem rather than an isolated incident.
Teams can use this information to evaluate failure modes, maintenance effectiveness, asset criticality, vendor performance, and lifecycle risk. Trend analysis may show that a maintenance interval is inadequate, a component is unsuitable, or an aging asset should be replaced. This evidence helps address causes instead of symptoms.
Building an Effective Integration Strategy
Biopharma organizations should begin by defining how CAPA records, deviations, change controls, work orders, calibration events, and equipment records relate to one another. Each asset should have a consistent and unique identifier across relevant systems.
Roles and responsibilities must also be clear. Quality should approve compliance-related decisions, while engineering, facilities, metrology, and maintenance personnel provide technical expertise and complete assigned work. Procedures should define documentation expectations, escalation requirements, approvals, and the circumstances that require change control or requalification.
Electronic systems used in regulated operations should have appropriate access controls, audit trails, record retention, review processes, and validation based on intended use and risk. Employees must be trained to create complete, accurate, and contemporaneous records.
Finally, organizations should use meaningful performance indicators. Repeat deviations, overdue work orders, emergency maintenance rates, calibration failures, CAPA aging, and effectiveness-check outcomes can reveal whether improvements are sustainable.
Strengthen Compliance Through Better Asset Control
Connecting CAPA with asset management turns quality commitments into controlled, measurable work. It gives investigators better evidence, helps technical teams address underlying equipment risks, and provides a clearer record for internal reviews and regulatory inspections.
GL Technologies helps pharmaceutical and biopharmaceutical organizations strengthen their equipment programs through calibration, qualification, validation, asset management, and compliance-focused technical services. By improving the connection between quality systems and asset performance, GL-Tec can help your facility reduce recurring issues, support data integrity, and maintain a state of control. Contact GL-Tec to discuss solutions tailored to your laboratory or manufacturing operation.
About GL Technologies
GL Technologies, based in San Diego, is a specialized service provider catering to the highly regulated industries of biopharmaceuticals, pharmaceuticals, medical devices, and government sectors. The company focuses on delivering expert solutions in equipment calibration, validation, and compliance services, ensuring that clients meet stringent GMP (Good Manufacturing Practice) and FDA regulations. GL technologies is a trusted partner from commissioning new plants to decommissioning with compliance. GL can place dedicated motivated quality personnel on site anywhere. A program can be designed or revamped for the customers needs from design of CMMS to SOP development, specification development and performance of calibrations.
With a dedicated team of 29 technicians, GL Technologies offers precision calibration, preventative maintenance, and qualification services for laboratory and production equipment used in critical manufacturing and research processes. The company’s expertise is supporting its clients in maintaining regulatory compliance and operational efficiency.
As a full-service company specializing in equipment calibration, repair, and certification services for biopharmaceutical, pharmaceutical, and medical device industries. Our team has extensive experience working with sPRT calibrations along with CMMS software, HPLC OQ validation, and fume hood certifications. Companies of all sizes rely on our team to implement, maintain, and keep their research and manufacturing processes compliant with regulatory standards. Other specialties include building maintenance systems, and mass spectrometry calibrations. GL Tec specializes in IQ OQ PQ services for clients throughout San Diego, San Francisco, Los Angeles, Orange County, and Riverside!